Archives of Neuroscience

Published by: Kowsar

A Review of Geoepidemiological Differences of Multiple Sclerosis in Iran and Other Middle East Countries

Zahra Tolou-Ghamari 1 , *
Author Information
1 Isfahan Neurosciences Research Centre, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Archives of Neuroscience: July 01, 2015, 2 (3); e22028
  • Published Online: December 30, 2014
  • Article Type: Review Article
  • Received: July 13, 2014
  • Revised: September 1, 2014
  • Accepted: November 12, 2014
  • DOI: 10.5812/archneurosci.22028

To Cite: Tolou-Ghamari Z. A Review of Geoepidemiological Differences of Multiple Sclerosis in Iran and Other Middle East Countries, Arch Neurosci. 2015 ; 2(3):e22028. doi: 10.5812/archneurosci.22028.

Copyright © 2014, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun. 2010; 34(3)-77[DOI][PubMed]
  • 2. Al Tahan AM, Alsharoqi I, Bohlega SA, Dahdaleh M, Daif A, Deleu D, et al. Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region. Int J Neurosci. 2014; 124(9): 635-41[DOI][PubMed]
  • 3. Wikipedia . Middle East.
  • 4. Kingwell E, Marriott JJ, Jette N, Pringsheim T, Makhani N, Morrow SA. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013; 13: 128[DOI][PubMed]
  • 5. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010; 9(5): 520-32[DOI][PubMed]
  • 6. Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 2013; 19(2 Suppl)-20[PubMed]
  • 7. Benamer HT, Ahmed ES, Al-Din AS, Grosset DG. Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci. 2009; 278(1-2): 1-4[DOI][PubMed]
  • 8. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013; 70(5-6): 356-63[DOI][PubMed]
  • 9. Etemadifar M, Abtahi SH. Multiple sclerosis in Isfahan, Iran: Past, Present and Future. Int J Prev Med. 2012; 3(5): 301-2[PubMed]
  • 10. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology. 2006; 27(1): 39-44[DOI][PubMed]
  • 11. Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler. 2011; 17(8): 1022-7[DOI][PubMed]
  • 12. Akhtar N, Elsetouhy A, Deleu D, Kamran S, AlHail H, Elalamy O. Newly diagnosed multiple sclerosis in state of Qatar. Clin Neurol Neurosurg. 2013; 115(8): 1333-7[DOI][PubMed]
  • 13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13(3): 227-31[DOI][PubMed]
  • 14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1): 121-7[PubMed]
  • 15. Tolou-Ghamari Z, Shaygannejad V, Ashtari F. Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital. Int J Prev Med. 2013; 4-8[PubMed]
  • 16. Rezaali S, Khalilnezhad A, Naser Moghadasi A, Chaibakhsh S, Sahraian MA. Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Iran J Neurol. 2013; 12(4): 136-43[PubMed]
  • 17. Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S. Incidence and prevalence of multiple sclerosis in southeastern Iran. Clin Neurol Neurosurg. 2013; 115(3): 304-8[DOI][PubMed]
  • 18. Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, Pakdaman H. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol. 2010; 64(6): 331-6[DOI][PubMed]
  • 19. Middleton LT, Dean G. Multiple sclerosis in Cyprus. J Neurologic Sci. 103(1): 29-36[DOI]
  • 20. Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Badry R, Metwally NA, et al. Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt. Neuropsychiatr Dis Treat. 2013; 9: 767-71[DOI][PubMed]
  • 21. Boru UT, Tasdemir M, Guler N, Ayik ED, Kumas A, Yildirim S, et al. Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey. Neuroepidemiology. 2011; 37(3-4): 231-5[DOI][PubMed]
  • 22. Turk Boru U, Alp R, Sur H, Gul L. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology. 2006; 27(1): 17-21[DOI][PubMed]
  • 23. Alroughani R, Ahmed SF, Behbahani R, Khan R, Thussu A, Alexander KJ, et al. Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Mult Scler. 2014; 20(5): 543-7[DOI][PubMed]
  • 24. Dean G, Aksoy H, Akalin T, Middleton L, Kyriallis K. Multiple sclerosis in the Turkish- and Greek-speaking communities of Cyprus. A United Nations (UNHCR) Bicommunal Project. J Neurol Sci. 1997; 145(2): 163-8[PubMed]
  • 25. Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Hamidian Jahromi A, Aghighi M, et al. Significant increase in the prevalence of multiple sclerosis in iran in 2011. Iran J Med Sci. 2014; 39(2): 152-3[PubMed]
  • 26. Zarei M, Basiri N, Jamnejad A, Eskandari MH. Prevalence of Escherichia coli O157:H7, Listeria monocytogenes and Salmonella spp. in Beef, Buffalo and Lamb Using Multiplex PCR. Jundishapur J Microbiol. 2013; 6(8)[DOI]
  • 27. Saharian MA, Shakaouri Rad A. , Motamedi M. Magnetic resonance imaging abnormalities in multiple sclerosis: A review. Iran J Radiol. 4(4): 231-9
  • 28. Shaygannejad V, Tolou-Ghamari Z. What is the Real Fate of Vitamin D in Multiple Sclerosis? Int J Prev Med. 2013; 4-64[PubMed]
  • 29. Shaygannejad V, Dehnavi SR, Ashtari F, Karimi S. Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population. Int J Prev Med. 2013; 4-83[PubMed]
  • 30. Mansouri B, Asadollahi S, Heidari K, Fakhri M. Risk factors for increased multiple sclerosis susceptibility in the Iranian population. J Clin Neurosci. 2014; [DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments